LONDON, April 03, 2024 (GLOBE NEWSWIRE) -- As per The Business Research Company’s Intestinal Pseudo Obstruction Treatment Global Market Report 2024, the intestinal pseudo obstruction treatment market has witnessed strong growth in recent years, with the market size projected to increase from $23.63 billion in 2023 to $24.98 billion in 2024, at a compound annual growth rate (CAGR) of 5.7%. This intestinal pseudo obstruction treatment market growth can be attributed to various factors such as the rise in chronic respiratory diseases, patient preference and compliance, convenience in self-administration, pediatric applications, and market expansion in allergic rhinitis treatment.
Anticipated Expansion in Market Size
The intestinal pseudo obstruction treatment market is expected to continue its upward trajectory, reaching $30.87 billion by 2028, with a CAGR of 5.4%. This intestinal pseudo obstruction treatment market growth is driven by factors including the increasing geriatric population, rising global respiratory issues, expanding applications in neurological disorders, personalized medicine trends, preventive healthcare initiatives, and market penetration in emerging economies. Notable trends in the forecast period include advances in formulation technologies, focus on pediatric and geriatric applications, rise in self-administration devices, nasal powder inhalers, and incorporation of biologics and peptides.
Learn More In-Depth On The Intestinal Pseudo Obstruction Treatment Market
Impact of Parkinson's Disease
The growing incidence of Parkinson’s disease (PD) is anticipated to drive the growth of the intestinal pseudo-obstruction treatment market. PD is a chronic neurodegenerative disorder that affects the central nervous system, resulting in constipation and intestinal pseudo-obstruction as non-motor symptoms. Effective treatments are required to address these symptoms. For instance, research supported by the Parkinson's Foundation indicates a significant increase in diagnoses of Parkinson's disease in the United States, highlighting the need for reliable treatment options.
Key Players and Innovations
Major companies operating in the intestinal pseudo-obstruction treatment market include Pfizer Inc., Johnson & Johnson, Merck & Co Inc., and others. These companies are focusing on the development of novel drug therapies, such as NHE3 inhibitor treatment therapy, to address the needs of patients. For instance, Ardelyx Inc. introduced IBSRELA, an NHE3 inhibitor treatment for irritable bowel syndrome with constipation (IBS-C) in adults, potentially improving gastrointestinal motility. Strategic acquisitions, such as Ironwood Pharmaceuticals' acquisition of VectivBio Holding AG, aim to enhance innovation pipelines and redefine the standard of care for GI patients.
Get A Free Sample Of The Global Intestinal Pseudo Obstruction Treatment Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=12995&type=smp
Regional Insights and Market Segmentation
North America dominated the intestinal pseudo obstruction treatment market in 2023, with various segments including condition (acute, chronic), treatment (medication, surgery, diet, other treatment), diagnosis (physical examination, biopsy, blood test, imaging tests, other diagnosis), and end user (hospitals and clinics, ambulatory care centers, other end users).
In conclusion, the intestinal pseudo obstruction treatment market is poised for significant growth, driven by various factors and innovations. With a focus on addressing emerging medical needs and advancing treatment options, the market offers numerous opportunities for growth and development.
Intestinal Pseudo Obstruction Treatment Global Market Report 2024 by The Business Research Company provides insights on the intestinal pseudo obstruction treatment market size, intestinal pseudo obstruction treatment market segments, intestinal pseudo obstruction treatment market trends, drivers and restraints, major competitors’ market positioning, revenues and market shares.
The Business Research Company has published over 7,500+ industry reports, covering more than 2,500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Check Out Similar Market Intelligence Reports By The Business Research Company:
Animal Intestinal Health Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report
Disposable Intestinal Wash Bags Global Market Report 2024
Gastrointestinal Stromal Tumor Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company is a market intelligence firm pioneering in company, market, and consumer research. With offices all around the world, TBRC has specialist consultants in a variety of fields, including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model – World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
